RESUMEN
The growing insights in the complex interactions between metastatic cancer-cells and platelets have revealed that platelet tumor cell interactions in the blood stream are an important factor supporting tumor metastasis. An increased coagulability of platelets facilitates the vascular evasion and establishment of solid tumor metastasis. Furthermore, platelets can support an immunosuppressive tumor microenvironment or shield tumor cells directly from engagement of cytotoxic lymphocytes as e.g., natural killer (NK) cells. Platelets are both in the tumor microenvironment and systemically the quantitatively most important source of TGF-ß, which is a key cytokine for immunosuppression in the tumor microenvironment. If similar platelet-tumor interactions are of physiological relevance in hematological malignancies remains less well-studied. This might be important, as T- and NK cell mediated graft vs. leukemia effects (GvL) are well-documented and malignant hematological cells have a high exposure to platelets compared to solid tumors. As NK cell-based immunotherapies gain increasing attention as a therapeutic option for patients suffering from hematological and other malignancies, we review the known interactions between platelets and NK cells in the solid tumor setting and discuss how these could also apply to hematological cancers. We furthermore explore the possible implications for NK cell therapy in patients with solid tumors and patients who depend on frequent platelet transfusions. As platelets have a protective and supportive effect on cancer cells, the impact of platelet transfusion on immunotherapy and the combination of immunotherapy with platelet inhibitors needs to be evaluated.
Asunto(s)
Plaquetas/inmunología , Vigilancia Inmunológica/fisiología , Neoplasias/inmunología , Escape del Tumor/fisiología , Animales , Humanos , Inmunoterapia , Células Asesinas Naturales/inmunología , Neoplasias/terapia , Microambiente Tumoral/inmunologíaRESUMEN
γδ T cells are a unique T cell subpopulation that are rare in secondary lymphoid organs but enriched in many peripheral tissues, such as the skin, intestines and lungs. By rapidly producing large amounts of cytokines, γδ T cells make key contributions to immune responses in these tissues. In addition to their immune surveillance activities, recent reports have unravelled exciting new roles for γδ T cells in steady-state tissue physiology, with functions ranging from the regulation of thermogenesis in adipose tissue to the control of neuronal synaptic plasticity in the central nervous system. Here, we review the roles of γδ T cells in tissue homeostasis and in surveillance of infection, aiming to illustrate their major impact on tissue integrity, tissue repair and immune protection.
Asunto(s)
Vigilancia Inmunológica/fisiología , Infecciones/inmunología , Linfocitos Intraepiteliales/fisiología , Membrana Mucosa/fisiología , Plasticidad Neuronal/fisiología , Regeneración/fisiología , Termogénesis/fisiología , Tejido Adiposo/metabolismo , Tejido Adiposo/fisiología , Regeneración Ósea/fisiología , Butirofilinas/metabolismo , Sistema Nervioso Central/fisiología , Femenino , Genitales Femeninos/fisiología , Encía/fisiología , Homeostasis , Humanos , Vigilancia Inmunológica/inmunología , Mucosa Intestinal/fisiología , Linfocitos Intraepiteliales/inmunología , Pulmón/fisiología , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/fisiologíaRESUMEN
Fasting, caloric restriction and foods or compounds mimicking the biological effects of caloric restriction, known as caloric restriction mimetics, have been associated with a lower risk of age-related diseases, including cardiovascular diseases, cancer and cognitive decline, and a longer lifespan. Reduced calorie intake has been shown to stimulate cancer immunosurveillance, reducing the migration of immunosuppressive regulatory T cells towards the tumor bulk. Autophagy stimulation via reduction of lysine acetylation, increased sensitivity to chemo- and immunotherapy, along with a reduction of insulin-like growth factor 1 and reactive oxygen species have been described as some of the major effects triggered by caloric restriction. Fasting and caloric restriction have also been shown to beneficially influence gut microbiota composition, modify host metabolism, reduce total cholesterol and triglyceride levels, lower diastolic blood pressure and elevate morning cortisol level, with beneficial modulatory effects on cardiopulmonary fitness, body fat and weight, fatigue and weakness, and general quality of life. Moreover, caloric restriction may reduce the carcinogenic and metastatic potential of cancer stem cells, which are generally considered responsible of tumor formation and relapse. Here, we reviewed in vitro and in vivo studies describing the effects of fasting, caloric restriction and some caloric restriction mimetics on immunosurveillance, gut microbiota, metabolism, and cancer stem cell growth, highlighting the molecular and cellular mechanisms underlying these effects. Additionally, studies on caloric restriction interventions in cancer patients or cancer risk subjects are discussed. Considering the promising effects associated with caloric restriction and caloric restriction mimetics, we think that controlled-randomized large clinical trials are warranted to evaluate the inclusion of these non-pharmacological approaches in clinical practice.
Asunto(s)
Restricción Calórica/métodos , Microbioma Gastrointestinal/fisiología , Vigilancia Inmunológica/fisiología , Neoplasias , Animales , Humanos , FenotipoRESUMEN
INTRODUCTION: The activating NKG2D receptor plays a central role in the immune recognition and elimination of abnormal self-cells by cytotoxic lymphocytes. NKG2D binding to cell stress-inducible ligands (NKG2DL) up-regulated on cancer cells facilitates their immunorecognition. Yet tumor cells utilize various escape mechanisms to avert NKG2D-based immunosurveillance. Hence, therapeutic strategies targeting the potent NKG2D/NKG2DL axis and such immune escape mechanisms become increasingly attractive in cancer therapy. AREAS COVERED: This perspective provides a brief introduction into the NKG2D/NKG2DL axis and its relevance for cancer immune surveillance. Subsequently, the most advanced therapeutic approaches targeting the NKG2D system are presented focusing on NKG2D-CAR engineered immune cells and antibody-mediated strategies to inhibit NKG2DL shedding by tumors. EXPERT OPINION: Thus far, NKG2D-CAR engineered lymphocytes represent the most advanced therapeutic approach utilizing the NKG2D system. Similarly to other tumor-targeting CAR approaches, NKG2D-CAR cells demonstrate powerful on-target activity, but may also cause off-tumor toxicities or lose efficacy, if NKG2DL expression by tumors is reduced. However, NKG2D-CAR cells also act on the tumor microenvironment curtailing its immunosuppressive properties, thus providing an independent therapeutic benefit. The potency of tumoricidal NKG2D-expressing lymphocytes can be further boosted by enhancing NKG2DL expression through small molecules and therapeutic antibodies inhibiting tumor-associated shedding of NKG2DL.
Asunto(s)
Inmunoterapia Adoptiva/métodos , Subfamilia K de Receptores Similares a Lectina de Células NK/metabolismo , Neoplasias/terapia , Linfocitos T Citotóxicos/metabolismo , Animales , Terapia Combinada/métodos , Terapia Genética/métodos , Humanos , Vigilancia Inmunológica/genética , Vigilancia Inmunológica/fisiología , Ligandos , Subfamilia K de Receptores Similares a Lectina de Células NK/genética , Subfamilia K de Receptores Similares a Lectina de Células NK/inmunología , Neoplasias/genética , Neoplasias/inmunología , Receptores Quiméricos de Antígenos/genética , Receptores Quiméricos de Antígenos/inmunología , Receptores Quiméricos de Antígenos/metabolismo , Linfocitos T Citotóxicos/trasplante , Microambiente Tumoral/inmunologíaRESUMEN
TITLE: Les cellules natural killer : des cibles prometteuses dans la thérapie contre le cancer. ABSTRACT: L'immuno-oncologie est une approche d'immunothérapie novatrice qui change le traitement des cancers en stimulant la capacité du système immunitaire à reconnaître et éliminer les cellules tumorales. Cette approche a pour but de mettre en place une immuno-surveillance anti-tumorale durable chez des patients pour lesquels les thérapies conventionnelles ont échoué.
Asunto(s)
Citotoxicidad Inmunológica/fisiología , Células Asesinas Naturales/fisiología , Oncología Médica/tendencias , Terapia Molecular Dirigida/tendencias , Neoplasias/terapia , Animales , Humanos , Vigilancia Inmunológica/fisiología , Oncología Médica/métodos , Terapia Molecular Dirigida/métodos , Neoplasias/inmunología , Neoplasias/patologíaRESUMEN
Cyclic GMP-AMP synthase (cGAS) recognition of cytosolic DNA is critical for immune responses to pathogen replication, cellular stress, and cancer. Existing structures of the mouse cGAS-DNA complex provide a model for enzyme activation but do not explain why human cGAS exhibits severely reduced levels of cyclic GMP-AMP (cGAMP) synthesis compared to other mammals. Here, we discover that enhanced DNA-length specificity restrains human cGAS activation. Using reconstitution of cGAMP signaling in bacteria, we mapped the determinant of human cGAS regulation to two amino acid substitutions in the DNA-binding surface. Human-specific substitutions are necessary and sufficient to direct preferential detection of long DNA. Crystal structures reveal why removal of human substitutions relaxes DNA-length specificity and explain how human-specific DNA interactions favor cGAS oligomerization. These results define how DNA-sensing in humans adapted for enhanced specificity and provide a model of the active human cGAS-DNA complex to enable structure-guided design of cGAS therapeutics.
Asunto(s)
ADN/metabolismo , Vigilancia Inmunológica/fisiología , Nucleotidiltransferasas/metabolismo , Animales , Benzofuranos/química , Benzofuranos/metabolismo , Sitios de Unión , Dominio Catalítico , Quimiotaxis/efectos de los fármacos , ADN/química , Humanos , Ratones , Simulación del Acoplamiento Molecular , Mutagénesis Sitio-Dirigida , Nucleótidos Cíclicos/metabolismo , Nucleótidos Cíclicos/farmacología , Nucleotidiltransferasas/antagonistas & inhibidores , Nucleotidiltransferasas/genética , Multimerización de Proteína , Estructura Terciaria de Proteína , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/aislamiento & purificación , Especificidad de la Especie , Vibrio cholerae/metabolismo , Vibrio cholerae/fisiologíaAsunto(s)
Células de Langerhans/inmunología , Envejecimiento de la Piel/inmunología , beta-Defensinas/metabolismo , Adulto , Anciano , Biopsia , Femenino , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/inmunología , Humanos , Vigilancia Inmunológica/fisiología , Inmunosenescencia/fisiología , Células de Langerhans/metabolismo , Masculino , Piel/citología , Piel/inmunología , Piel/metabolismo , beta-Defensinas/inmunologíaRESUMEN
INTRODUCTION: Immunotherapy aims to promote the immune system's activity against malignant cells by stimulating the response to several tumor antigens. STATE OF THE ART: Immunosurveillance may adjust the immunogenicity of tumors. To be effective, immunity must induce the specific activation of CD4+ and CD8+ T lymphocytes, as well as activation of innate immunity. Activator and inhibitory costimulatory molecules regulate T lymphocyte activation at immunity checkpoints such as PD-1/PD-L1 and CTLA-4. Adaptive immune resistance confers tumour resistance to immunosurveillance through these immune checkpoints. PERSPECTIVES: Approaches involving the combination of several immunotherapies with each other or with chemotherapy and radiotherapy and antibodies against other molecules of costimulation are under development. The development of biomarkers, which can select a targeted population and predict therapeutic response, represents a major challenge. Tumour high-throughput sequencing could refine "immunoscore". Intratumoral T cell receptor seems to represent a promising biomarker. CONCLUSIONS: Numerous challenges still remain in developing research approaches for the development of immunotherapies.
Asunto(s)
Inmunoterapia/estadística & datos numéricos , Neoplasias/terapia , Anticuerpos Monoclonales/uso terapéutico , Antígeno B7-H1/fisiología , Humanos , Sistema Inmunológico/fisiología , Vigilancia Inmunológica/fisiología , Inmunoterapia/métodos , Neoplasias/inmunología , Receptor de Muerte Celular Programada 1/fisiología , Escape del Tumor/fisiologíaAsunto(s)
Células Clonales/patología , Vigilancia Inmunológica/fisiología , Neoplasias/inmunología , Animales , Animales Modificados Genéticamente , Comunicación Celular/genética , Comunicación Celular/inmunología , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/inmunología , Células Clonales/inmunología , Perros , Drosophila , Femenino , Genes Supresores de Tumor , Humanos , Vigilancia Inmunológica/genética , Masculino , Proteínas de la Membrana/genética , Proteínas de la Membrana/fisiología , Ratones , Neoplasias/genética , Ratas , Proteínas Supresoras de Tumor/genética , Proteínas Supresoras de Tumor/fisiología , Pez CebraRESUMEN
Telocytes (TCs) are identified as a peculiar cell type of interstitial cells in various organs. The typical features of TCs from the other cells are the extending cellular process as telopodes with alternation of podomeres and podoms. Before the year of 2010, TCs were considered as interstitial Cajal-like cells because of the similar morphology and immunohistochemical features with interstitial cells of Cajal which were found more than 100 years ago and considered to be pacemakers for gut motility. Subsequently, it demonstrated that TCs were not Cajal-like cells, and thus the new name "telocyte" was proposed in 2010. With the help of different techniques, e.g., transmission electron microscopy, immunohistochemistry, or omics science, TCs have been detected in various tissues and organs from different species. The pathological role of TCs in different diseases was also studied. According to observation in situ or in vitro, TCs played a vital role in mechanical support, signaling transduction, tissue renewal or repair, immune surveillance, and mechanical sensor via establishing homo- or heterogenous junctions with neighboring cells to form 3D network or release extracellular vesicles to form juxtacrine and paracrine. This review will introduce the origin, distribution, morphology, functions, omics science, methods, and interaction of TCs with other cells and provide a better understanding of the new cell type.
Asunto(s)
Linaje de la Célula/fisiología , Vesículas Extracelulares/metabolismo , Uniones Intercelulares/metabolismo , Telocitos/citología , Animales , Bibliometría , Fenómenos Biomecánicos , Comunicación Celular , Biología Computacional , Vesículas Extracelulares/inmunología , Humanos , Vigilancia Inmunológica/fisiología , Uniones Intercelulares/inmunología , Regeneración/fisiología , Transducción de Señal , Telocitos/inmunología , Telocitos/metabolismoRESUMEN
In the last decade, a growing body of evidence has highlighted the major role of cancer immunosurveillance. The immune system can recognize tumor cells and keep them under check for long period of time, but is impeded by escape mechanisms induced by the tumor itself. Interestingly, the efficacy of chemotherapy has been shown to depend on the immune response, which in turn is potentiated by chemical agents, creating a positive feedback loop leading to long term tumor resistance. In this review, we summarize some mechanisms underlying the synergy between chemo- and immuno-therapy.
Asunto(s)
Antineoplásicos/uso terapéutico , Inmunoterapia , Neoplasias/terapia , Animales , Terapia Combinada/métodos , Sinergismo Farmacológico , Humanos , Vigilancia Inmunológica/efectos de los fármacos , Vigilancia Inmunológica/fisiología , Inmunoterapia/métodos , Neoplasias/inmunología , Neoplasias/patología , Resultado del Tratamiento , Escape del Tumor/efectos de los fármacos , Escape del Tumor/inmunologíaRESUMEN
Immunosurveillance constitutes the first step of cancer immunoediting in which developing malignant lesions are eliminated by antitumorigenic immune cells. However, the mechanisms by which neoplastic cells induce an immunosuppressive state to evade the immune response are still unclear. The transcription factor STAT3 has been implicated in breast carcinogenesis and tumor immunosuppression in advanced disease, but its involvement in early disease development has not been established. Here, we genetically ablated Stat3 in the tumor epithelia of the inducible PyVmT mammary tumor model and found that Stat3-deficient mice recapitulated the three phases of immunoediting: elimination, equilibrium, and escape. Pathologic analyses revealed that Stat3-deficient mice initially formed hyperplastic and early adenoma-like lesions that later completely regressed, thereby preventing the emergence of mammary tumors in the majority of animals. Furthermore, tumor regression was correlated with massive immune infiltration into the Stat3-deficient lesions, leading to their elimination. In a minority of animals, focal, nonmetastatic Stat3-deficient mammary tumors escaped immune surveillance after a long latency or equilibrium period. Taken together, our findings suggest that tumor epithelial expression of Stat3 plays a critical role in promoting an immunosuppressive tumor microenvironment during breast tumor initiation and progression, and prompt further investigation of Stat3-inhibitory strategies that may reactivate the immunosurveillance program.
Asunto(s)
Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Tolerancia Inmunológica/fisiología , Vigilancia Inmunológica/fisiología , Metástasis de la Neoplasia/patología , Factor de Transcripción STAT3/metabolismo , Microambiente Tumoral/fisiología , Animales , Carcinogénesis/metabolismo , Carcinogénesis/patología , Femenino , Neoplasias Mamarias Animales/metabolismo , Neoplasias Mamarias Animales/patología , RatonesRESUMEN
The lymphatic system is crucial for efficient immune surveillance and for the maintenance of a physiological pressure in the interstitial space. Even so, almost no information is available concerning the lymph drainage of the islets of Langerhans in the human pancreas. Immunohistochemical staining allowed us to distinguish lymphatic capillaries from blood capillaries. Almost no lymphatic capillaries were found within the islets in pancreatic biopsy specimens from subjects without diabetes or from subjects with type 1 or type 2 diabetes. Lymphatic capillaries were, however, found at the islet-exocrine interface, frequently located along blood capillaries and other fibrotic structures within or close to the islet capsule. Lymphatic capillaries were regularly found in the exocrine pancreas, with small lymphatic vessels located close to and around acini. Larger collecting lymphatic vessels were located in fibrotic septa between the exocrine lobules and adjacent to the ductal system of the pancreas. In summary, we report a pronounced deficiency of lymphatic capillaries in human islets, a finding with implications for immune surveillance and the regulation of interstitial fluid transport in the endocrine pancreas as well as for the pathophysiology of both type 1 and type 2 diabetes.
Asunto(s)
Vigilancia Inmunológica/fisiología , Islotes Pancreáticos/citología , Vasos Linfáticos/citología , Páncreas/citología , Adolescente , Adulto , Anciano , Biopsia , Capilares/citología , Capilares/patología , Recuento de Células , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/patología , Diabetes Mellitus Tipo 2/inmunología , Diabetes Mellitus Tipo 2/patología , Humanos , Islotes Pancreáticos/irrigación sanguínea , Islotes Pancreáticos/inmunología , Islotes Pancreáticos/patología , Vasos Linfáticos/patología , Persona de Mediana Edad , Páncreas/irrigación sanguínea , Páncreas/inmunología , Páncreas/patología , Adulto JovenRESUMEN
Sheltered in a bony cage, populated by cells with little regenerative potential, the central nervous system (CNS) could likely not withstand classic inflammation without risking major sequelae. As a consequence, it had to develop an original way to provide surveillance, defence and reparation, which relies on both the complex architecture of the periphery-nervous parenchyma exchange zones, and the tightly regulated collaboration between all the cell populations that reside in or pass through the CNS. Despite its tight regulation, neuroinflammation is sometimes the cause of irreversible loss but it is also where the solution stands. The specific immune crosstalk that takes place in the CNS needs to be decoded in order to identify the best therapeutic strategies aimed at helping the CNS to restore homeostasis in problematic situations, such as in the case of neurodegenerative disorders. This review deals with this double-edged sword nature of neuroinflammation.
Asunto(s)
Sistema Nervioso Central/inmunología , Sistema Nervioso Central/patología , Inflamación/etiología , Enfermedades Neurodegenerativas/etiología , Astrocitos/fisiología , Barrera Hematoencefálica/fisiología , Sistema Nervioso Central/citología , Humanos , Vigilancia Inmunológica/fisiología , Microglía/fisiología , Enfermedades Neurodegenerativas/inmunología , Neuronas/fisiología , Oligodendroglía/fisiologíaRESUMEN
Toll-like receptors (TLRs) are membrane-bound microbial sensors that mediate important host-to-microbe responses. Cell biology aspects of TLR function have been intensively studied in professional immune cells, in particular the macrophages and dendritic cells, but not well explored in other specialized epithelial cell types. The adult intestinal epithelial cells are in close contact with trillions of enteric microbes and engage in lifelong immune surveillance. Mature intestinal epithelial cells, in contrast to immune cells, are highly polarized. Recent studies suggest that distinct mechanisms may govern TLR traffic and compartmentalization in these specialized epithelial cells to establish and maintain precise signaling of individual TLRs. We, using immune cells as references, discuss here the shared and/or unique molecular machineries used by intestinal epithelial cells to control TLR transport, localization, processing, activation, and signaling. A better understanding of these mechanisms will certainly generate important insights into both the mechanism and potential intervention of leading digestive disorders, in particular inflammatory bowel diseases.
Asunto(s)
Células Epiteliales/metabolismo , Vigilancia Inmunológica/fisiología , Mucosa Intestinal/citología , Modelos Biológicos , Receptores Toll-Like/metabolismo , Humanos , Enfermedades Inflamatorias del Intestino/genética , Enfermedades Inflamatorias del Intestino/metabolismo , Mucosa Intestinal/metabolismo , Receptores de Lipopolisacáridos/metabolismo , Antígeno 96 de los Linfocitos/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Transporte de Proteínas/fisiología , Proteínas de Transporte Vesicular/metabolismoRESUMEN
Cellular senescence has been recently linked to the promotion of age-related pathologies, including a decline in regenerative capacity. While such capacity deteriorates with age in mammals, it remains intact in species such as salamanders, which have an extensive repertoire of regeneration and can undergo multiple episodes through their lifespan. Here we show that, surprisingly, there is a significant induction of cellular senescence during salamander limb regeneration, but that rapid and effective mechanisms of senescent cell clearance operate in normal and regenerating tissues. Furthermore, the number of senescent cells does not increase upon repetitive amputation or ageing, in contrast to mammals. Finally, we identify the macrophage as a critical player in this efficient senescent cell clearance mechanism. We propose that effective immunosurveillance of senescent cells in salamanders supports their ability to undergo regeneration throughout their lifespan.
Asunto(s)
Envejecimiento/fisiología , Macrófagos/citología , Células Madre Mesenquimatosas/fisiología , Regeneración/fisiología , Urodelos/fisiología , Cicatrización de Heridas/fisiología , Animales , Efecto Espectador , Muerte Celular , Proliferación Celular , Senescencia Celular/fisiología , Extremidades/lesiones , Extremidades/fisiología , Vigilancia Inmunológica/fisiología , Macrófagos/inmunología , Células Madre Mesenquimatosas/citología , Fagocitosis , Cultivo Primario de CélulasAsunto(s)
Sistema Inmunológico/fisiología , Vigilancia Inmunológica/fisiología , Neoplasias/inmunología , Inmunidad Adaptativa , Antígenos de Neoplasias/inmunología , Linfocitos B/inmunología , Antígeno CTLA-4/inmunología , Humanos , Evasión Inmune/inmunología , Inmunidad Innata , Memoria Inmunológica , Linfocitos T/inmunología , Escape del Tumor/inmunologíaRESUMEN
Microglia cells are the major orchestrator of the brain inflammatory response. As such, they are traditionally studied in various contexts of trauma, injury, and disease, where they are well-known for regulating a wide range of physiological processes by their release of proinflammatory cytokines, reactive oxygen species, and trophic factors, among other crucial mediators. In the last few years, however, this classical view of microglia was challenged by a series of discoveries showing their active and positive contribution to normal brain functions. In light of these discoveries, surveillant microglia are now emerging as an important effector of cellular plasticity in the healthy brain, alongside astrocytes and other types of inflammatory cells. Here, we will review the roles of microglia in adult hippocampal neurogenesis and their regulation by inflammation during chronic stress, aging, and neurodegenerative diseases, with a particular emphasis on their underlying molecular mechanisms and their functional consequences for learning and memory.
Asunto(s)
Hipocampo/crecimiento & desarrollo , Vigilancia Inmunológica/fisiología , Inflamación/fisiopatología , Microglía/fisiología , Neurogénesis/fisiología , Fagocitosis/fisiología , Envejecimiento/inmunología , Envejecimiento/fisiología , Animales , Hipocampo/citología , Hipocampo/fisiología , Humanos , Enfermedades Neurodegenerativas/patología , Enfermedades Neurodegenerativas/fisiopatología , Neurogénesis/inmunología , Estrés PsicológicoAsunto(s)
Dengue/inmunología , Enfermedades del Sistema Inmune/inmunología , Inmunidad Activa , Mastocitos/inmunología , Animales , Dengue/complicaciones , Virus del Dengue/inmunología , Humanos , Enfermedades del Sistema Inmune/virología , Memoria Inmunológica , Vigilancia Inmunológica/fisiología , Dengue Grave/inmunología , Enfermedades Vasculares/etiología , Enfermedades Vasculares/inmunología , Enfermedades Vasculares/virologíaRESUMEN
Adenosine, a purine nucleoside, is present at high concentrations in tumors, where it contributes to the failure of immune cells to eliminate cancer cells. The mechanisms responsible for the immunosuppressive properties of adenosine are not fully understood. We tested the hypothesis that adenosine's immunosuppressive functions in human T lymphocytes are in part mediated via modulation of ion channels. The activity of T lymphocytes relies on ion channels. KCa3.1 and Kv1.3 channels control cytokine release and, together with TRPM7, regulate T cell motility. Adenosine selectively inhibited KCa3.1, but not Kv1.3 and TRPM7, in activated human T cells. This effect of adenosine was mainly mediated by A2A receptors, as KCa3.1 inhibition was reversed by SCH58261 (selective A2A receptor antagonist), but not by MRS1754 (A2B receptor antagonist), and it was mimicked by the A2A receptor agonist CGS21680. Furthermore, it was mediated by the cAMP/protein kinase A isoform (PKAI) signaling pathway, as adenylyl-cyclase and PKAI inhibition prevented adenosine effect on KCa3.1. The functional implication of the effect of adenosine on KCa3.1 was determined by measuring T cell motility on ICAM-1 surfaces. Adenosine and CGS21680 inhibited T cell migration. Comparable effects were obtained by KCa3.1 blockade with TRAM-34. Furthermore, the effect of adenosine on cell migration was abolished by pre-exposure to TRAM-34. Additionally, adenosine suppresses IL-2 secretion via KCa3.1 inhibition. Our data indicate that adenosine inhibits KCa3.1 in human T cells via A2A receptor and PKAI, thereby resulting in decreased T cell motility and cytokine release. This mechanism is likely to contribute to decreased immune surveillance in solid tumors.